A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain

Clinical trial NCT05624853 · COMPLETED

Trial details

NCT number: NCT05624853
Sponsor: Yuhan Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neuropathic Pain Diabetes Mellitus, Type 2

Start date: 2020-05-12
Primary completion: 2022-12-20
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.